S. 4302
Referred to CommitteeBiologics Market Transparency Act of 2022
Introduced 5/25/2022•117th Congress•Senate
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
5/25/2022 • Senate
Summary
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
Introduced in Senate • 5/25/2022
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (4)
Party Breakdown
2
Democrats
2
Republicans
0
Independents
Sponsor
S[
Cosponsors (3)
S[
S[
S[
Bill Journey
Originated in the Senate
Introduced
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in Senate5/25/2022